Interrogating the Safety & Efficacy Profile of JAK1 Selective Inhibitors in Inflammatory Disorders to Apply Learnings to the Skin
Time: 11:30 am
day: Pre-Conference Workshop Day
Details:
- What can we learn from advances of JAK inhibitors in alternative indications?
- Investigating mechanistic data and early clinical trial biomarker data to assess efficacy and safety of JAK1 inhibitors
- Navigating clinical decision making and illuminating opportunities for indication expansion in inflammatory disorders
